Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SNDL

DatePrice TargetRatingAnalyst
7/17/2024Speculative Buy
Canaccord Genuity
8/16/2022$5.00Hold → Speculative Buy
Canaccord Genuity
5/3/2022$0.60 → $0.70Underperform → Market Perform
BMO Capital Markets
More analyst ratings

$SNDL
Press Releases

Fastest customizable press release news feed in the world

See more
  • SNDL Reports Fourth Quarter and Full Year 2024 Financial and Operational Results

    The Company reports Record Full Year Net Revenue, Gross Profit and Gross Margin, as well as positive Cash Flow and Free Cash Flow  CALGARY, AB, March 18, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter ended December 31, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation and shareholder letter on its website, found at https://sndl.com. The Co

    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care
  • SNDL to Announce Fourth Quarter 2024 and Full Year 2024 Financial Results on March 18, 2025

    CALGARY, AB, Feb. 25, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2024 financial results for the period ended December 31, 2024, before market opens on Tuesday, March 18, 2025. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 18, 2025. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/yxxmbsby ABOUT SNDL INC.  SNDL is a public company w

    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care
  • HYTN and SNDL to Collaborate on GMP-Compliant Vape Cartridge Development for Global Markets

    VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE:HYTN, FSE: 85W0, OTC:HYTNF) ("HYTN" or the "Company"), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a collaboration agreement (the Agreement) with SNDL Inc. (NASDAQ:SNDL) ("SNDL"), one of the world's largest vertically integrated cannabis companies, to jointly develop Good Manufacturing Practices (GMP) compliant vape cartridges. Leveraging HYTN's GMP-certified facility and expertise in quality system development, SNDL will provide specialized equipment, cannabis consumables, and the required capital to meet stringent regulatory

    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

$SNDL
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$SNDL
SEC Filings

See more

$SNDL
Leadership Updates

Live Leadership Updates

See more
  • SNDL Appoints New Chief Information Officer and New President, Liquor Division

    CALGARY, AB, Nov. 21, 2024 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") is pleased to announce the appointments of Phil McBride as Chief Information Officer and Navroop Sandhawalia as President, Liquor Division. "SNDL's success is driven by our commitment to talent density and our leaders are the foundation of our performance culture," said Zach George, Chief Executive Officer of SNDL.  "Phil's extensive expertise in technology and digital innovation, paired with Nav's financial acumen and best-in-class retail experience will further strengthen our executio

    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care
  • SNDL Announces 2024 Annual General Meeting Results

    CALGARY, AB, July 30, 2024 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders of common shares (the "Shareholders") at the Annual General Meeting (the "Meeting") were passed. At the Meeting, Shareholders approved: (i) fixing the number of directors of the board at six (6); (ii) electing each of Gregory Mills, Zachary George, Lori Ell, Frank Krasovec, Bryan Pinney and Gregory Turnbull as directors of the Company for the ensuing year; and (iii) re-appointing Marcum LLP as the auditors of the Company for the ensu

    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care
  • Skymint Assets Acquired from Receivership; Sunstream USA Builds on Parallel Acquisition

    CALGARY, AB, Oct. 13, 2023 /PRNewswire/ - SunStream Bancorp Inc. ("SunStream") is pleased to announce a receivership court order (the "Sale Order") granting the sale of certain assets of Greenpeak Industries Inc. and certain affiliated entities d.b.a. Skymint ("Skymint") to Skymint Acquisition Co. (the "Skymint Transaction"), a newly formed designee entity of Tropics LP ("Tropics"). Tropics is a limited partnership fully owned by an affiliate of Sunstream, a joint venture sponsored by SNDL Inc. (NASDAQ:SNDL) ("SNDL").  Skymint Acquisition Co. is anticipated to be part of the S

    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

$SNDL
Financials

Live finance-specific insights

See more
  • SNDL Reports Fourth Quarter and Full Year 2024 Financial and Operational Results

    The Company reports Record Full Year Net Revenue, Gross Profit and Gross Margin, as well as positive Cash Flow and Free Cash Flow  CALGARY, AB, March 18, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter ended December 31, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation and shareholder letter on its website, found at https://sndl.com. The Co

    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care
  • SNDL to Announce Fourth Quarter 2024 and Full Year 2024 Financial Results on March 18, 2025

    CALGARY, AB, Feb. 25, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2024 financial results for the period ended December 31, 2024, before market opens on Tuesday, March 18, 2025. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 18, 2025. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/yxxmbsby ABOUT SNDL INC.  SNDL is a public company w

    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care
  • SNDL Reports Third Quarter 2024 Financial and Operational Results

    The Company reports record Gross Margin and positive Cash Flow and Free Cash Flow CALGARY, AB, Nov. 5, 2024 /CNW/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the third quarter ended September 30, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation on its website, found at https://sndl.com. The Company will hold a conference call and webcast presentation at 10:00 a.m. EST (8:00 a.m. MST) o

    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

$SNDL
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more